Synthesis and biological evaluation of novel heterocyclic derivatives of combretastatin A-4-Reference-Cited by-同舟云学术

Synthesis and biological evaluation of novel heterocyclic derivatives of combretastatin A-4

Published:2012-12 Issue:23 Volume:22 Page:7227-7231
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Nguyen Thi Thanh Binh,Lomberget Thierry,Tran Ngoc Chau,Colomb Evelyne,Nachtergaele Lore,Thoret Sylviane,Dubois Joëlle,Guillaume Joren,Abdayem Rawad,Haftek Marek,Barret Roland

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference50 articles.

1. Microtubule-binding agents: a dynamic field of cancer therapeutics

2. Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle

3. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4

4. Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the potential therapeutic role of benzofuran derivatives in cancer treatment;Journal of Molecular Structure;2024-12

2. A concise protocol for the synthesis of 2-alkenylindoles through [4 + 1] annulation of aminobenzyl phosphonium salts with acrylaldehydes;Green Chemistry;2024

3. Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers;Bioorganic Chemistry;2023-12

4. SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis;Cancer Letters;2023-02

5. Recent Trends in Tubulin-Binding Combretastatin A-4 Analogs for Anticancer Drug Development;Current Medicinal Chemistry;2021-12-02